Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1977
On the mechanism of renaturation of proteins containing disulfide bonds
H Taniuchi, A S Acharya, G Andria, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1997
Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia
H Taniuchi, Y Fujibayashi, Y Yonekura, et al.
The Journal of Biological Chemistry
|
September 25, 1977
Nuclease B. A possible precursor of nuclease A, an extracellular nuclease of Staphylococcus aureus
A Davis, I B Moore, D S Parker, et al.
The Journal of Biological Chemistry
|
May 25, 1971
Staphylococcal nuclease (Foggi strain). II. The amino acid sequence
J L Cone, C L Cusumano, H Taniuchi, et al.
Biological & Pharmaceutical Bulletin
|
August 1, 1995
Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET)
H Taniuchi, Y Fujibayashi, H Okazawa, et al.
Annals of Nuclear Medicine
|
November 1, 1993
Basic evaluation of 67Ga labeled digoxin derivative as a metal-labeled bifunctional radiopharmaceutical
Y Fujibayashi, Y Takemura, H Taniuchi, et al.
Nuclear Medicine and Biology
|
June 25, 1998
Intracellular metabolism of 99mTc-d,l-HMPAO in vitro: a basic approach for understanding the hyperfixation mechanism in damaged brain
Y Fujibayashi, H Taniuchi, A Waki, et al.
Biological & Pharmaceutical Bulletin
|
February 1, 1993
Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging
Y Fujibayashi, K Wada, H Taniuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1997
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential
Y Fujibayashi, H Taniuchi, Y Yonekura, et al.
Annals of Nuclear Medicine
|
February 1, 1995
Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging
Y Fujibayashi, H Taniuchi, K Wada, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Advances in Experimental Medicine and Biology
|
January 1, 1977
On the mechanism of renaturation of proteins containing disulfide bonds
H Taniuchi, A S Acharya, G Andria, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1997
Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia
H Taniuchi, Y Fujibayashi, Y Yonekura, et al.
The Journal of Biological Chemistry
|
September 25, 1977
Nuclease B. A possible precursor of nuclease A, an extracellular nuclease of Staphylococcus aureus
A Davis, I B Moore, D S Parker, et al.
The Journal of Biological Chemistry
|
May 25, 1971
Staphylococcal nuclease (Foggi strain). II. The amino acid sequence
J L Cone, C L Cusumano, H Taniuchi, et al.
Biological & Pharmaceutical Bulletin
|
August 1, 1995
Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET)
H Taniuchi, Y Fujibayashi, H Okazawa, et al.
Annals of Nuclear Medicine
|
November 1, 1993
Basic evaluation of 67Ga labeled digoxin derivative as a metal-labeled bifunctional radiopharmaceutical
Y Fujibayashi, Y Takemura, H Taniuchi, et al.
Nuclear Medicine and Biology
|
June 25, 1998
Intracellular metabolism of 99mTc-d,l-HMPAO in vitro: a basic approach for understanding the hyperfixation mechanism in damaged brain
Y Fujibayashi, H Taniuchi, A Waki, et al.
Biological & Pharmaceutical Bulletin
|
February 1, 1993
Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging
Y Fujibayashi, K Wada, H Taniuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1997
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential
Y Fujibayashi, H Taniuchi, Y Yonekura, et al.
Annals of Nuclear Medicine
|
February 1, 1995
Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging
Y Fujibayashi, H Taniuchi, K Wada, et al.
Page
of 7